Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the <scp>GIMEMA AML2320</scp> trial

Raffaele Palmieri, Alfonso Piciocchi, Stefano Soddu, Marco Frigeni, Erika Borlenghi, Nicola Fracchiolla, Maria Paola Martelli, Ernesta Audisio, Alessandro Cignetti, Giacomo Gianfaldoni, Calogero Vetro, Nicola di Rienzo, Daniela Esposito, Ambra Di Veroli, Carmine Selleri, Federica Gigli, Antonio Curti, Antonino Mulè, Catello Califano, Sara Bigliardi, Massimo Breccia, Claudio Fozza, Monica Bocchia, Albana Lico, Federico Simonetti, Elisabetta Pierdomenico, Monia Marchetti, Ilaria Cerroni, Francesco Buccisano, Maria Ilaria Del Principe, Luca Maurillo, Giovangiacinto Paterno, Paola Fazi, Marco Vignetti, Giuseppe Rossi, Alessandro Rambaldi, Adriano Venditti

Open source

DOI: 10.1111/bjh.70752
Published: 2026-08-17
Container: British Journal of Haematology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70752,
  title = {Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the
                    <scp>GIMEMA AML2320</scp>
                    trial},
  author = {Raffaele Palmieri and Alfonso Piciocchi and Stefano Soddu and Marco Frigeni and Erika Borlenghi and Nicola Fracchiolla and Maria Paola Martelli and Ernesta Audisio and Alessandro Cignetti and Giacomo Gianfaldoni and Calogero Vetro and Nicola di Rienzo and Daniela Esposito and Ambra Di Veroli and Carmine Selleri and Federica Gigli and Antonio Curti and Antonino Mulè and Catello Califano and Sara Bigliardi and Massimo Breccia and Claudio Fozza and Monica Bocchia and Albana Lico and Federico Simonetti and Elisabetta Pierdomenico and Monia Marchetti and Ilaria Cerroni and Francesco Buccisano and Maria Ilaria Del Principe and Luca Maurillo and Giovangiacinto Paterno and Paola Fazi and Marco Vignetti and Giuseppe Rossi and Alessandro Rambaldi and Adriano Venditti},
  year = {2026},
  journal = {British Journal of Haematology},
  doi = {10.1111/bjh.70752},
  url = {https://doi.org/10.1111/bjh.70752}
}

RIS

TY  - JOUR
TI  - Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the
                    <scp>GIMEMA AML2320</scp>
                    trial
AU  - Raffaele Palmieri
AU  - Alfonso Piciocchi
AU  - Stefano Soddu
AU  - Marco Frigeni
AU  - Erika Borlenghi
AU  - Nicola Fracchiolla
AU  - Maria Paola Martelli
AU  - Ernesta Audisio
AU  - Alessandro Cignetti
AU  - Giacomo Gianfaldoni
AU  - Calogero Vetro
AU  - Nicola di Rienzo
AU  - Daniela Esposito
AU  - Ambra Di Veroli
AU  - Carmine Selleri
AU  - Federica Gigli
AU  - Antonio Curti
AU  - Antonino Mulè
AU  - Catello Califano
AU  - Sara Bigliardi
AU  - Massimo Breccia
AU  - Claudio Fozza
AU  - Monica Bocchia
AU  - Albana Lico
AU  - Federico Simonetti
AU  - Elisabetta Pierdomenico
AU  - Monia Marchetti
AU  - Ilaria Cerroni
AU  - Francesco Buccisano
AU  - Maria Ilaria Del Principe
AU  - Luca Maurillo
AU  - Giovangiacinto Paterno
AU  - Paola Fazi
AU  - Marco Vignetti
AU  - Giuseppe Rossi
AU  - Alessandro Rambaldi
AU  - Adriano Venditti
PY  - 2026
JO  - British Journal of Haematology
DO  - 10.1111/bjh.70752
UR  - https://doi.org/10.1111/bjh.70752
ER  -

APA

Palmieri, R., Piciocchi, A., Soddu, S., Frigeni, M., Borlenghi, E., Fracchiolla, N., Martelli, M. P., Audisio, E., Cignetti, A., Gianfaldoni, G., Vetro, C., Rienzo, N. D., Esposito, D., Veroli, A. D., Selleri, C., Gigli, F., Curti, A., Mulè, A., Califano, C., Bigliardi, S., Breccia, M., Fozza, C., Bocchia, M., Lico, A., Simonetti, F., Pierdomenico, E., Marchetti, M., Cerroni, I., Buccisano, F., Principe, M. I. D., Maurillo, L., Paterno, G., Fazi, P., Vignetti, M., Rossi, G., Rambaldi, A., & Venditti, A. (2026). Real‐world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the <scp>GIMEMA AML2320</scp> trial. British Journal of Haematology. https://doi.org/10.1111/bjh.70752

Source records

crossref · retrieved 2026-09-26T10:49:03.446Z